ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 163 filers reported holding ZAI LAB LTD in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $534,820 | -12.3% | 22,000 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $610,060 | -16.6% | 22,000 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $731,720 | +68.6% | 22,000 | +73.2% | 0.01% | +133.3% |
| Q3 2022 | $434,000 | -1.4% | 12,700 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $440,000 | -21.3% | 12,700 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $559,000 | -60.6% | 12,700 | -43.8% | 0.00% | -66.7% |
| Q4 2021 | $1,420,000 | +6.1% | 22,597 | +77.9% | 0.01% | -25.0% |
| Q3 2021 | $1,338,000 | -40.5% | 12,700 | 0.0% | 0.01% | -36.8% |
| Q2 2021 | $2,248,000 | – | 12,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |